Annual Cash & Cash Equivalents
$124.60 K
-$7.82 M-98.43%
December 31, 2022
Summary
- As of February 8, 2025, SCPS annual cash & cash equivalents is $124.60 thousand, with the most recent change of -$7.82 million (-98.43%) on December 31, 2022.
- During the last 3 years, SCPS annual cash & cash equivalents has risen by +$87.90 thousand (+239.51%).
- SCPS annual cash & cash equivalents is now -98.43% below its all-time high of $7.94 million, reached on December 31, 2021.
Performance
SCPS Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$362.10 K
-$1.04 M-74.16%
June 30, 2023
Summary
- As of February 8, 2025, SCPS quarterly cash and cash equivalents is $362.10 thousand, with the most recent change of -$1.04 million (-74.16%) on June 30, 2023.
- Over the past year, SCPS quarterly cash and cash equivalents has increased by +$51.30 thousand (+16.51%).
- SCPS quarterly cash and cash equivalents is now -95.61% below its all-time high of $8.26 million, reached on March 31, 2021.
Performance
SCPS Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
SCPS Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -98.4% | +16.5% |
| 3 y3 years | +239.5% | - |
| 5 y5 years | -21.2% | - |
SCPS Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -98.4% | at low | -95.4% | +190.6% |
| 5 y | 5-year | -98.4% | +239.5% | -95.6% | +886.6% |
| alltime | all time | -98.4% | +7229.4% | -95.6% | +886.6% |
Scopus BioPharma Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $362.10 K(-74.2%) |
| Mar 2023 | - | $1.40 M(+1024.8%) |
| Dec 2022 | $124.60 K(-98.4%) | $124.60 K(-59.9%) |
| Sep 2022 | - | $310.80 K(-73.1%) |
| Jun 2022 | - | $1.16 M(-70.9%) |
| Mar 2022 | - | $3.97 M(-50.0%) |
| Dec 2021 | $7.94 M | $7.94 M(+118.7%) |
| Sep 2021 | - | $3.63 M(-42.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2021 | - | $6.26 M(-24.2%) |
| Mar 2021 | - | $8.26 M(+350.6%) |
| Dec 2020 | $1.83 M(+4892.1%) | $1.83 M(+335.6%) |
| Sep 2020 | - | $420.60 K(+1046.0%) |
| Dec 2019 | $36.70 K(+2058.8%) | $36.70 K(-95.8%) |
| Jun 2019 | - | $869.40 K(+59.1%) |
| Mar 2019 | - | $546.50 K |
| Dec 2018 | $1700.00(-98.9%) | - |
| Dec 2017 | $158.20 K | - |
FAQ
- What is Scopus BioPharma annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Scopus BioPharma?
- What is Scopus BioPharma annual cash & cash equivalents year-on-year change?
- What is Scopus BioPharma quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Scopus BioPharma?
- What is Scopus BioPharma quarterly cash and cash equivalents year-on-year change?
What is Scopus BioPharma annual cash & cash equivalents?
The current annual cash & cash equivalents of SCPS is $124.60 K
What is the all time high annual cash & cash equivalents for Scopus BioPharma?
Scopus BioPharma all-time high annual cash & cash equivalents is $7.94 M
What is Scopus BioPharma annual cash & cash equivalents year-on-year change?
Over the past year, SCPS annual cash & cash equivalents has changed by -$7.82 M (-98.43%)
What is Scopus BioPharma quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of SCPS is $362.10 K
What is the all time high quarterly cash and cash equivalents for Scopus BioPharma?
Scopus BioPharma all-time high quarterly cash and cash equivalents is $8.26 M
What is Scopus BioPharma quarterly cash and cash equivalents year-on-year change?
Over the past year, SCPS quarterly cash and cash equivalents has changed by +$51.30 K (+16.51%)